Loading company…
Riskpilot
← Back to search
Sign in
Get full access
HYPERTHERMICS PROTEIN AS
AS
Active
Org 933232247
Vikemyra 1, 6065 Ulsteinvik
Engineering activities and related technical consultancy · NACE 7112
Est. 2024
— employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 0
EBITDA margin
—
Equity ratio
4.7%
Financial strength
Net profit 2024
NOK 308
EBITDA — year on year
NOK millions
0M
0M
1M
1M
1M
0M
2024
Key figures
Annual report 2024
Revenue
NOK 0
—
EBITDA
NOK -2
—
Net profit
NOK 308
—
Total assets
NOK 525K
—
Equity
NOK 25K
—
Employees
—
—
Company information
Legal name
HYPERTHERMICS PROTEIN AS
Org number
933232247
Legal form
Aksjeselskap
NACE code
7112 · Engineering activities and related technical consultancy
Founded
11. april 2024
Share capital
NOK 30 000
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Utvikle og kommersialisere hyperthermics teknologi rettet mot protein som sluttprodukt, gjennom enten salg eller drift av egne enheter.
Contact
Address
Vikemyra 1, 6065 Ulsteinvik
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Engineering activities and related technical consultancy
Companies in Ulstein
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2024
Income statement
NOK thousands
Item
2024
Revenue
0
Staff expenses
−0
EBITDA
−0
Depreciation & amort.
−0
EBIT
−0
Net financials
0
Profit before tax
0
Tax
−0
Net profit
0
Balance sheet
NOK thousands
Item
2024
Total assets
525
Equity
25
Long-term debt
0
Short-term debt
500
Total debt
500
Financial ratios
5-year trend
EBITDA margin
-200.0%
This company
15.8%
Market median
-1366% vs market
2024
2024
Equity ratio
4.7%
This company
38.2%
Market median
-88% vs market
2024
2024
Return on equity
1.3%
This company
18.4%
Market median
-93% vs market
2024
2024
Net profit margin
30800.0%
This company
8.1%
Market median
+380147% vs market
2024
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2024
2024
Debt / equity
20.39×
This company
0.62×
Market median
-3189% vs market
2024
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Age
Other directorships
HN
Harald Nordal
Chairman
2024
—
—
ES
Erik Sondre Paulsen
Board of Directors
2024
—
—
EJ
Elias Johan Breiteig Liavaag
Board of Directors
2026
—
—
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of HYPERTHERMICS PROTEIN AS also hold positions in
0
other companies.
Person
Role here
Other companies
Harald Nordal
Chairman
0 companies
Erik Sondre Paulsen
Board of Directors
0 companies
Elias Johan Breiteig Liavaag
Board of Directors
0 companies